- Home
- DRRX vs SLRX Comparison
DRRX vs SLRX Comparison
Compare DRRX & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- SLRX
- Stock Information
- Founded
- DRRX 1998
- SLRX N/A
- Country
- DRRX United States
- SLRX United States
- Employees
- DRRX N/A
- SLRX N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- DRRX Health Care
- SLRX Health Care
- Exchange
- DRRX Nasdaq
- SLRX Nasdaq
- Market Cap
- DRRX N/A
- SLRX 1.8M
- IPO Year
- DRRX 2000
- SLRX N/A
- Fundamental
- Price
- DRRX $0.61
- SLRX $0.75
- Analyst Decision
- DRRX Hold
- SLRX
- Analyst Count
- DRRX 1
- SLRX 0
- Target Price
- DRRX N/A
- SLRX N/A
- AVG Volume (30 Days)
- DRRX 47.0K
- SLRX 3.6M
- Earning Date
- DRRX 08-12-2025
- SLRX 08-08-2025
- Dividend Yield
- DRRX N/A
- SLRX N/A
- EPS Growth
- DRRX N/A
- SLRX N/A
- EPS
- DRRX N/A
- SLRX N/A
- Revenue
- DRRX $1,856,000.00
- SLRX N/A
- Revenue This Year
- DRRX N/A
- SLRX N/A
- Revenue Next Year
- DRRX $673.00
- SLRX N/A
- P/E Ratio
- DRRX N/A
- SLRX N/A
- Revenue Growth
- DRRX 79.84
- SLRX N/A
- 52 Week Low
- DRRX $0.48
- SLRX $0.45
- 52 Week High
- DRRX $1.74
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- DRRX 46.88
- SLRX 41.73
- Support Level
- DRRX $0.57
- SLRX $0.66
- Resistance Level
- DRRX $0.69
- SLRX $0.90
- Average True Range (ATR)
- DRRX 0.06
- SLRX 0.12
- MACD
- DRRX -0.00
- SLRX -0.03
- Stochastic Oscillator
- DRRX 48.12
- SLRX 16.46
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.